Project Grant R13HS029600
Award Date
9/30/24
Completion Date
9/29/27
Dollars Obligated
$100K
Funding Federal Agency
Center for Evidence and Practice Improvement
Awarding Federal Agency
Division of Grants Management
Awardee
Auburn University (DMQNDJDHTDG4)
Federal Grant Program
93.226
Assistance Type
Project Grant
Place of Performance
Auburn University, AL 36849, USA
Similar Awards
This $779,969 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to improve perioperative care for patients with opioid use disorder. The key objectives are to: Prospectively capture patient-reported pain and opioid use data among individuals with opioid use disorder undergoing common surgical procedures, and develop evidence-based prescribing guidelines. Qualitatively assess the perioperative experiences...
This $3,000,000 Project Grant award from the U.S. Department of Health and Human Services (HHS) Health Resources and Services Administration (HRSA) under the Rural Health Research Centers program (CFDA 93.155) supports a 4-year initiative to improve opioid response efforts in rural communities. The awardee, The Center For Wellness And Recovery Of Northeast GA Corp, will deliver research, technical assistance, and other publicly disseminated resources to help address healthcare challenges faced...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research to study the impact of the 2016 CDC guidelines on opioid prescribing on disparities in pain management among vulnerable older adult populations. The $676,000 award to the Icahn School of Medicine at Mount Sinai will examine the unintended effects of the guidelines on opioid utilization for cancer pain and acute pain from orthopedic trauma in three groups: older adults with...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research program) provides $636,957 to Mayo Clinic to conduct a double-blind, placebo-controlled clinical trial evaluating the effects of prescription opioids on brain structure and cognition in older adults with chronic pain. The study aims to determine whether opioid exposure is associated with changes in white matter integrity and global cognitive function. The primary outcome is white matter integrity as...
This federal Project Grant award of $400,000.00, granted by the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program, supports research to assess the consistency of results and conclusions about patient safety in systematic reviews (SRs) of drug interventions. The project aims to use advanced natural language processing techniques to extract and synthesize evidence on drug-related harms from SRs, real-world...
This $701,959 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to improve perioperative care for patients with opioid tolerance in the United States. The key objectives are to: Prospectively capture patient-reported opioid use and pain outcomes among opioid-tolerant individuals undergoing common surgical procedures, and develop a clinical care pathway to optimize outcomes across a network of hospitals...
This Project Grant award of $1,362,860 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a study on the co-use of cannabis and prescription opioids among emerging adults in medical settings. The study aims to identify individual risk factors and malleable protective factors that contribute to the development of opioid and cannabis co-use and related problems in the context of pain management. The research will...
This Project Grant award for $144,362.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research to evaluate a pharmacist-integrated model of opioid use disorder (OUD) treatment in primary care settings to increase naloxone co-prescribing. The research aims to: 1) describe federal, state, and clinic-level policies and interventions impacting naloxone co-prescribing, 2) investigate care team knowledge and attitudes...
The federal Project Grant award of $1,500,000 was provided by the U.S. Department of Health and Human Services' Health Resources and Services Administration (HRSA) under the Rural Health Research Centers program (CFDA 93.155). The award will support Rural Health Inc., a non-profit federally qualified health center located in Anna, Illinois, in their efforts to address opioid use disorders and related healthcare challenges in the rural communities of Union, Massac, and Johnson Counties. Through...
This $400,000 Project Grant award from the Center for Financing Access and Cost Trends (CFACT) of the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ) supports a nationwide retrospective study examining the impact of changes to Medicare hospice drug policies implemented in 2014. The study, titled "IMPACT OF NEW HOSPICE DRUG POLICIES ON EXPENDITURES, UTILIZATION, PRESCRIBING QUALITY, AND ACCESS," will analyze changes in Medicare Part D...